¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"biological analysis through DNA transfer."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gene transfer
    À¯ÀüÀÚÀü´Þ
  • gene transfer therapy
    À¯ÀüÀÚÀ̽Ŀä¹ý
  • gamete intrafallopian transfer
    »ý½Ä¼¼Æ÷Àڱðü³»À̽Ä, »ý½Ä¼¼Æ÷Àڱðü³»Àü´Þ
  • heat transfer rate
    ¿­Àü´Þ·ü
  • magnetization transfer technique
    ÀÚ¼ºÈ­Àü´Þ±â¼ú
  • mass energy transfer coefficient
    Áú·®¿¡³ÊÁöÀüÀ̰è¼ö
  • magnetic transfer contrast
    ÀÚ±âÈ­Àü´Þ´ëÁ¶µµ
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • magnetization transfer pulse
    ÀÚ±âÈ­Àü´ÞÆÄ
  • magnetization transfer ratio
    ÀÚ±âÈ­Àü´ÞºñÀ²
  • passive transfer
    ¼öµ¿Àü´Þ
  • resistance transfer factor
    ³»¼ºÀü´ÞÀÎÀÚ
  • tendon transfer
    ÈûÁÙÀüÀÌ(¼ú), °ÇÀüÀÌ(¼ú)
  • zygote intrafallopian transfer
    Á¢ÇÕÀÚÀڱðü³»À̽Ä, Á¢ÇÕüÀڱðü³»Àü´Þ
  • biological
    »ý¹°ÇÐÀû-
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • survival analysis
    »ýÁ¸ºÐ¼®
  • system analysis
    °èÅëºÐ¼®
  • meta-analysis
    ¸ÞŸºÐ¼®
  • self-analysis
    ÀÚ±âºÐ¼®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • biological filtration
    »ý¹°ÇÐÀû°Å¸£±â
  • biological hazard
    »ý¹°ÇÐÀûÀ§ÇØ
  • biological marker
    »ý¹°ÇÐÀûÁöÇ¥
  • biological microscope
    »ý¹°Çö¹Ì°æ
  • biological preparation
    »ý¹°ÇÐÁ¦Á¦
  • biological process
    »ý¹°ÇÐÀû¹æ¹ý, »ý¹°ÇÐÀû°úÁ¤
  • biological product
    »ý¹°ÇÐÀûÁ¦Á¦
  • biological purification
    »ý¹°ÇÐÀûÁ¤È­
  • biological rhythm
    »ýü¸®µë
  • biological spectrum
    »ý¹°½ºÆåÆ®·³
  • biological stain
    »ý¹°ÇÐÀû¿°»ö
  • biological standardization
    »ý¹°ÇÐÀûÇ¥ÁØÈ­
  • biological survey
    »ý¹°ÇÐÀûÁ¶»ç
  • biological test
    »ý¹°ÇÐÀû½ÃÇè
  • biological transmission
    »ý¹°ÇÐÀûÀüÆÄ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heat transfer =h. transmission
    ¿­Àü´Þ(ËçËøËÀ).
  • heat transfer rate
    ¿­Àü´Þ·ü(¡­ëÒ).
  • heat transfer rate
    ¿­Àü´Þ·ü(ÊÙËô).
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • placenta transfer
    ŹÝÀüÀÌ, ŹÝÅë°ú
  • placental transfer
    ŹÝÀ̵¿.
  • placental transfer
    ŹÝÀ̵¿(÷ÃÚïì¹ÔÑ)
  • radiation,linear energy transfer (let)
    ¼±»ó¿¡³ÊÁöÀüȯ(àÊß¾¡­ï®üµ)
  • Data analysis
    Á¤º¸ºÐ¼®
  • Decision analysis
    °áÁ¤ºÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®(¡­ÝÂà°), ¹æ»çÈ­(Û¯ÞÒûù)ºÐ¼®.
  • activation analysis
    ¹æ»çÈ­ºÐ¼®, Ȱ¼ºÈ­ºÐ¼®
  • amniotic fluid analysis
    ¾ç¼öºÐ¼®
  • analysis
    ºÐ¼®
  • analysis of variance technique
    ºÐ»ê±â¼úºÐ¼®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dna oncogenic virus
    DNA ¹ß¾Ï ¹ÙÀÌ·¯½º(¡­Û¡äß¡­)
  • double helix, DNA model
  • double-stranded DNA
    µÎ°¡´ÚDNA
  • hybridization, DNA-RNA
    DNA-RNA ¦Áö¿ì±â, DNA-RNA ºÎÇÕÈ­(~ݬùêûù)
  • infectious (-tive) DNA
    °¨¿°¼º DNA
  • recombinant DNA
    ÀçÁ¶ÇÕ DNA
  • adoptive transfer
    ÀÎÀÔ(¸é¿ª)Àü´Þ(ìÚìýØóæ¹îîÓ¹).
  • adoptive transfer
    ÀÔ¾çÀü´Þ
  • afterimage transfer test
    ÀÜ»óÀüÀ̰˻ç
  • antibody transfer
    Ç×üÀÌÀÔ(¡­ì¹ìý).
  • conjugal transfer
    Á¢ÇÕÀü´Þ
  • drug resistance transfer factor
    ¾àÁ¦³»¼ºÀü´ÞÀÎÀÚ
  • electron transfer
    ÀüÀÚÀ̵¿(¡­ì¹ÔÑ), ÀüÀÚ¿î¹Ýü(¡­ê¡Úæô÷).
  • electron transfer system
    ÀüÀÚ¿î¹Ýü.
  • electron transfer system
    ÀüÀÚÀü´Þ°è(¡­ì¹ÔÑ), ÀüÀÚ¿î¹Ýü(¡­ê¡Úæô÷).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼® (üÀàõûùÝÂà°)
  • amino acid analysis
    ¾Æ¹Ì³ë»ê(ß«) ºÐ¼®(ÝÂà°)
  • analysis of variance
    ºÐ»êºÐ¼®(ÝÂߤÝÂà°)
  • conformational analysis
    ÀÔüÇüÅ ºÐ¼®(Ø¡ô÷û¡÷¾ÝÂà°)
  • control analysis
    ´ëÁ¶ ºÐ¼®(ÓßðÎÝÂà°)
  • covalent structure analysis
    °øÀ¯°áÇÕ ±¸Á¶ºÐ¼®(ÍìêóÌ¿ùêϰðãÝÂà°)
  • differential thermal analysis
    Â÷ ¿­ºÐ¼®(ó¬æðÝÂà°)
  • displacement analysis
    ´ëÄ¡ºÐ¼®(ÓÛöÇÝÂà°)
  • double isotope dilution analysis
    ÀÌÁß µ¿À§¿ø¼Ò Èñ¼®ºÐ¼®(ì£ñìÔÒêÈêªáÈýüà·ÝÂà°)
  • elementary analysis
    ¿ø¼Ò ºÐ¼® (êªáÈÝÂà°)
  • elution analysis
    ¿ë¸® ºÐ¼® (éÁ×îÝÂà°)
  • end-group analysis
    Á¾´Ü±â ºÐ¼® (ðûÓ®ÐñÝÂà°)
  • fluctuation analysis
    ¿äµ¿ ºÐ¼®(èôÔÑÝÂà°)
  • gravimetric analysis
    ¹«°Ô ºÐ¼®(ÝÂà°)
  • inhibition analysis
    ÀúÇØºÐ¼®(îÁúªÝÂà°)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • magnetization transfer ratio [=MTR]
    ÀÚÈ­Àü´ÞºñÀ²
  • magnetization transfer suppression
    ÀÚÈ­Àü´Þ¾ïÁ¦
  • magnetization transfer technique
    ÀÚÈ­Àü´Þ±â¼ú
  • transfer
    Àü´Þ, ÀüÀÌ, Àü¼ÛÇÏ´Ù
  • analysis
    ºÐ¼®
  • case analysis
    Áõ·ÊºÐ¼®
  • computerized image analysis
    ÄÄÇ»ÅÍ¿µ»óºÐ¼®
  • image analysis
    ¿µ»óºÐ¼®
  • in vitro analysis
    °ü³»ºÐ¼®
  • in vivo analysis
    »ýü³»ºÐ¼®
  • infrared spectroscopic analysis
    Àû¿Ü¼±ºÐ±¤ºÐ¼®
  • quantitative analysis
    Á¤·®ºÐ¼®
  • radiometric analysis
    ¹æ»ç¼±ºÐ¼®
  • sequential analysis
    ¼øÂ÷ÀûºÐ¼®
  • spectral analysis
    ½ºÆåÆ®·³ºÐ¼®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MEDPAR Medical Provider Analysis and Review; Medicare Provider Analysis and Review
MRA magnetic resonance angiography; main renal artery; marrow repopulation activity; medical record anal...
ACT achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ...
FT Fallot tetralogy; false transmitter; family therapy; fast twitch; fatigue trial; fibrous tissue; fin...
pa through the anus [Lat. per anum]; yearly [Lat. per annum]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DNA MTase DNA methytransferase
DNA-MG DNA Malignancy Grade
DNA-PK DNA dependent protein kinase
DNA P DNA polymerase
DNA-SSB DNA single strand break
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • file transfer protocol
    ÆÄÀÏ Àü¼Û ÇÁ·ÎÅäÄÝ
  • fluorescence excitation transfer immunoassay
    Çü±¤ ¿©±â ÀüÀÌ ¸é¿ª ÃøÁ¤
  • heat transfer
    ¿­ Àü´Þ
    µ¿ÀǾî=heat transmission.
  • linear energy transfer
    ¼± ¿¡³ÊÁö ºÎ¿©
  • magnetic transfer contrast
    ÀÚÈ­ Àü´Þ ´ëÁ¶µµ
  • magnetization transfer
    ÀÚÈ­ Àü´Þ
  • magnetization transfer imaging
    ÀÚÈ­ Àü´Þ ¿µ»ó
  • magnetization transfer ratio
    ÀÚÈ­ Àü´Þ ºñÀ²
  • magnetization transfer technique
    ÀÚÈ­ Àü´Þ ±â¼ú
  • transcapillary transfer
    ¸ð¼¼°ü À̵¿
  • transfer
    Àü´Þ, ÀüÀÌ, Àü¼ÛÇÏ´Ù
    ÇÑ Àå¼Ò¿¡¼­ ´Ù¸¥ Àå¼Ò·Î ¾î¶² ¹°ÁúÀÌ À̵¿µÇ´Â °Í.
  • transfer coping
    ±Ý¼ÓÁ¦ °ñ¹«, Áö´ëÄ¡ ¸ðÇü °íÁ¤¿ë °ñ¹«, ÀüÀÌ¿ë ÄÚÇÎ
    ÀÎ»ó¿¡ Ä¡ÇüÀ» À§Ä¡½Ã۴µ¥ »ç¿ëÇÏ´Â ±Ý¼Ó ¶Ç´Â ¾ÆÅ©¸± ¼öÁö·Î µÈ ÇǺ¹¹°À̳ª ca
  • transfer factor
    Àü´Þ ÀÎÀÚ, ÀüÀÌ ¿äÀÎ
  • transfer RNA
    Àü´Þ RNA
  • biological action
    »ý¹° ÀÛ¿ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
biological agent <microbiology> A disease-causing microorganism or virus, or other toxic biological matter, which is used as a weapon during war.
(21 Mar 1998)
biological assay <technique> Once a pharmaceutical protein is isolated from the cells in which it was grown, researchers perform tests to measure the protein's biological activity.
It must maintain a certain minimal level of biological activity to be used for animal or clinical testing or, later, for market. Researchers also test to confirm that the isolated protein is identical to the desired protein.
(21 Mar 1998)
biological assessment A specific process required as part of an environmental assessment. An evaluation of potential effects of a proposed project on proposed, endangered, threatened, and sensitive animal and plant species and their habitats.
(05 Dec 1998)
biological availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.
(12 Dec 1998)
biological chemistry The scientific study of the chemistry of living cells, tissues, organs and organisms.
(09 Oct 1997)
biological clock <biology, physiology> An internal biological mechanism which controls certain biological rhythms and biocycles, such as metabolism, sleep cycles, photosynthesis.
(21 Mar 1998)
biological clocks The physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioural phenomena in plants and animals. The pineal gland, which receives input from the optic nerves and connects to the hypothalamus, may be the biological clock in humans.
(12 Dec 1998)
biological coefficient Rarely used term denoting the energy expended by the body at rest.
(05 Mar 2000)
biological containment <molecular biology> Refers to any number of methods to contain genetically engineered organisms by creating biochemical barriers to prevent them from growing outside the laboratory.
In the case of bacteria and yeasts, genes in the organisms may be altered so that they need to have a supply of a nutrient that is normally found only in the laboratory.
(21 Mar 1998)
biological control <agriculture> The agricultural use of living things, such as parasites, diseases, and predators, to control or eliminate others, such as weeds and pests, rather than by using chemicals (herbicides and pesticides).
(21 Mar 1998)
biological dressings Human or animal tissue used as temporary wound coverings.
(12 Dec 1998)
biological engineering <agriculture> A type of artificial selection, the creation of plant or animal breeds that are agriculturally or industrially useful.
Compare: natural selection.
(21 Mar 1998)
biological factors Compounds made by living organisms. They have biological or physiological activities.
(12 Dec 1998)
biological half-life <biochemistry, biology> This is the time required for one-half of the total amount of a particular substance in a biological system to be consumed or broken down by biological processes when the rate of removal is approximately exponential.
Toxic chemicals with a long biological half-life (such as some pesticides) will tend to accumulate in the body and are, therefore, more likely to be harmful. A substance with a short biological half-life may still accumulate if a portion of it it becomes tightly bound to bone or other tissues, even if most of it is quickly cleared from the body.
(21 Mar 1998)
biological hazard potential <radiobiology> Measure of the hazard posed by a given quantity of radioactive material in which the variation in biological effects of the various elements are accounted for.
See: integrated biological hazard potential.
(21 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • negative transfer
    ¼Ò±ØÀû ÀüÀÌ(ÇнÀ °úÁ¤¿¡¼­ ¼±Çà ÇнÀÀÌ ÈÄÀÇ ÇнÀÀ» ¹æÇØ ¾ïÁ¦
  • transfer
    Àüȯ;À̵¿;ÀüÇÐ;ÀüÀÓ;(±Ç¸®ÀÇ)ÀÌÀü;(¸íÀÇÀÇ)º¯°æ;´ëü;ȯ;°¥¾ÆÅ¸±â;°¥¾ÆÅ¸´Â Ç¥
  • transfer
    ¿Å´Ù;ÀüÀԵǴÙ;°¥¾ÆÅ¸´Ù
  • transfer
    ¿Å±â´Ù;³ª¸£´Ù;¾çµµÇÏ´Ù;Àü»çÇÏ´Ù;ÀüÀÓ½ÃŰ´Ù
  • transfer RNA
    ÀüÀÌ RNA;¿î¹Ý RNA
  • transfer company
    ±Ù°Å¸® ¿î¼Ûȸ»ç(µÎ Å͹̳Π¿ª ±¸°£ µî)
  • transfer table
    (Áö»ó½Ä)õÂ÷´ë
  • transfer tax
    »ó¼Ó¼¼;¾çµµ¼¼
  • be through with ~
    ~¸¦ ³¡³»´Ù,³¡¸¶Ä¡´Ù
  • come through
    À̰ܳ»´Ù; ÀÔ¼öµÇ´Ù
  • get through
    -À» ³¡ ¸¶Ä¡´Ù
  • get through to
    ÀÌÇØ½ÃŰ´Ù; µµÂøÇÏ´Ù
  • get through with
    ³¡³»´Ù; °ßµð¾î³»´Ù
  • go through
    Åë°úÇÏ´Ù; ¼ö·áÇÏ´Ù; Á¶»çÇÏ´Ù
  • go through with
    ³¡±îÁö ÇØ³»´Ù; ¿Ï¼ºÇÏ´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á